Making Sense

J.P. Morgan

“Making Sense,” the podcast channel from J.P. Morgan’s Commercial & Investment Bank, brings you views and analysis from the Investment Banking, Markets and Research businesses. In each episode, experts discuss the latest market outlooks, trends and developments impacting our complex global economy. Subscribe now for insights that will help you navigate the world we live in.

Making Sense

Financing the Future of Defense: Admiral Pierre Vandier on Innovation and Investment

Episode discussion: Admiral Vandier on NATO's shift to protracted warfare and the need for private capital in defense adoption

Speakers’ claims: Admiral Pierre Vandier, NATO's Supreme Allied Commander Transformation, argues that the war in Ukraine has shifted conflict from crisis management to protracted warfare, making industrial production capacity decisive. He notes that military R&D has lagged behind civilian innovation for 30 years, creating a cultural barrier to adopting new technologies like commercial drones. Vandier suggests that NATO's primary challenge is now adoption at scale, requiring a shift from innovation boards to adoption boards. He calls for private capital and banks to inject speed and new KPIs into the defense sector, moving investment from legacy systems to future technologies.

Defense IndustryNATOPrivate Capital
12 min0 assets7 claims to verify
Making Sense

Revving the ETF vehicle: Roundhill’s CEO on DRAM, next-gen innovation and more

Episode discussion: Roundhill CEO Dave Mazza discusses ETF innovation, DRAM exposure, and retail investor influence

Speakers’ claims: Dave Mazza, CEO of Roundhill, explains the firm's mission to serve millennial and Gen Z investors through de-aged financial advice. He highlights MAGS as the first ETF providing precise exposure to the Magnificent 7 via cash equities and total return swaps. Mazza also details the DRAM ETF, which offers direct access to memory semiconductor leaders like Micron and Samsung, addressing the limitations of traditional semiconductor or South Korean equity proxies. He distinguishes between structural themes like AI-driven memory demand and short-term catalysts, noting that competitor launches validate these theses. Finally, Mazza asserts that retail investors now account for 20-25% of US daily volume, up from pre-COVID levels, and influence product development through online communities.

ETFsSemiconductorsMemory Chips
15 min0 assets10 claims to verify
Making Sense

US midterms: Fiscal, market and geopolitical implications of the "blue wave"

Episode discussion: US midterms blue wave implications for fiscal policy, markets, and geopolitics

Speakers’ claims: Bruce Kasman and Derek Chollet discuss the macroeconomic and geopolitical implications of Democratic control of Congress. Kasman argues that Democratic leverage will likely roll back healthcare spending cuts, increasing the deficit, while tariffs are expected to rise. He notes that oil price declines and potential slowdowns in tech spending are key variables, with Fed turnover possibly increasing under a moderated presidential pressure. Chollet describes a 'blue tsunami' that may curb tariffs and embolden Congress on Ukraine and Iran, while predicting a hawkish bipartisan shift in US-China relations. He also highlights the surprising nature of Lula's re-election in Brazil and its impact on regional trade dynamics.

US Fiscal PolicyFederal ReserveGeopolitics
28 min0 assets10 claims to verify
Making Sense

Rebuilding resilience in America’s pharmaceutical supply chain

Episode discussion: Alex Gorsky discusses reshoring pharmaceutical supply chains and AI's role in drug discovery

Speakers’ claims: Former J&J CEO Alex Gorsky argues that the COVID-19 pandemic shifted board priorities from supply chain efficiency to resilience. He highlights a critical dependency on foreign sources for generic drugs, noting that approximately 85% of US drug volume consists of generics sourced internationally. Gorsky advocates for a multifaceted approach to reshoring, including strategic stockpiles and coordination with allied nations. He also predicts that AI will drastically reduce drug discovery timelines by synthesizing complex biological datasets. The discussion concludes with advice for healthcare leaders to prioritize patience and innovation.

PharmaceuticalsSupply ChainArtificial Intelligence
15 min1 assets10 claims to verify
Making Sense

Capital is tilting East: Inside Asia’s AI gold rush

Episode discussion: Asia's AI-driven growth and supply chain shifts reshape global capital flows amid geopolitical fragmentation

Speakers’ claims: Joyce Chang and Schuert Leynard discuss how Asia's 4.5% GDP growth is outpacing the US and Europe, driven by AI demand and manufacturing renaissance. They note that AI capex is rising to ~$1.5 trillion, with memory chips becoming critical infrastructure. The speakers highlight a 'China 2.0 shock' where Chinese exports compete with Europe, while supply chains shift to ASEAN nations like Vietnam and Thailand. Investor sentiment is selectively risk-on, focusing on quality and diversification rather than universal AI bets. Cybersecurity risks are intensifying, with vulnerability exploitation windows compressing to minutes.

Asia AISupply ChainGeopolitics
19 min0 assets10 claims to verify